[Bacteriological study on clindamycin-2-palmitate (author's transl)].
D000818:Animals; D001419:Bacteria / Q000187:drug effects; D002981:Clindamycin / Q000494:pharmacology* / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004352:Drug Resistance, Microbial; D051379:Mice; D008826:Microbial Sensitivity Tests; D010169:Palmitic Acids / Q000494:pharmacology; D011008:Pneumococcal Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000188:drug therapy; D013297:Streptococcus pyogenes
D010169:Palmitic Acids; D002981:Clindamycin